180 related articles for article (PubMed ID: 26364275)
1. Safety and Preliminary Efficacy of the Acetylcholinesterase Inhibitor Huperzine A as a Treatment for Cocaine Use Disorder.
De La Garza R; Verrico CD; Newton TF; Mahoney JJ; Thompson-Lake DG
Int J Neuropsychopharmacol; 2015 Sep; 19(3):pyv098. PubMed ID: 26364275
[TBL] [Abstract][Full Text] [Related]
2. Rivastigmine does not alter cocaine-induced subjective effects or self-administration.
Patel M; Verrico CD; De La Garza R
Pharmacol Biochem Behav; 2019 Oct; 185():172758. PubMed ID: 31430484
[TBL] [Abstract][Full Text] [Related]
3. Time Course, Behavioral Safety, and Protective Efficacy of Centrally Active Reversible Acetylcholinesterase Inhibitors in Cynomolgus Macaques.
Hamilton LR; Schachter SC; Myers TM
Neurochem Res; 2017 Jul; 42(7):1962-1971. PubMed ID: 27900576
[TBL] [Abstract][Full Text] [Related]
4. Phase I study on the pharmacokinetics and tolerance of ZT-1, a prodrug of huperzine A, for the treatment of Alzheimer's disease.
Jia JY; Zhao QH; Liu Y; Gui YZ; Liu GY; Zhu DY; Yu C; Hong Z
Acta Pharmacol Sin; 2013 Jul; 34(7):976-82. PubMed ID: 23624756
[TBL] [Abstract][Full Text] [Related]
5. The serotonin-2C agonist Lorcaserin delays intravenous choice and modifies the subjective and cardiovascular effects of cocaine: A randomized, controlled human laboratory study.
Pirtle JL; Hickman MD; Boinpelly VC; Surineni K; Thakur HK; Grasing KW
Pharmacol Biochem Behav; 2019 May; 180():52-59. PubMed ID: 30811963
[TBL] [Abstract][Full Text] [Related]
6. Smoked cocaine self-administration is decreased by modafinil.
Hart CL; Haney M; Vosburg SK; Rubin E; Foltin RW
Neuropsychopharmacology; 2008 Mar; 33(4):761-8. PubMed ID: 17568397
[TBL] [Abstract][Full Text] [Related]
7. Assessment of safety, cardiovascular and subjective effects after intravenous cocaine and lofexidine.
De La Garza R; Galloway GP; Newton TF; Mendelson J; Haile CN; Dib E; Hawkins RY; Chen CY; Mahoney JJ; Mojsiak J; Lao G; Anderson A; Kahn R
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():44-52. PubMed ID: 24316175
[TBL] [Abstract][Full Text] [Related]
8. Treatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.
Verrico CD; Haile CN; Mahoney JJ; Thompson-Lake DG; Newton TF; De La Garza R
Drug Alcohol Depend; 2014 Aug; 141():72-8. PubMed ID: 24928479
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of natural acetylcholinesterase inhibitor huperzine A in the treatment of Alzheimer's disease: an updated meta-analysis.
Wang BS; Wang H; Wei ZH; Song YY; Zhang L; Chen HZ
J Neural Transm (Vienna); 2009 Apr; 116(4):457-65. PubMed ID: 19221692
[TBL] [Abstract][Full Text] [Related]
10. Huperzine a as potential treatment of Alzheimer's disease: an assessment on chemistry, pharmacology, and clinical studies.
Ha GT; Wong RK; Zhang Y
Chem Biodivers; 2011 Jul; 8(7):1189-204. PubMed ID: 21766442
[TBL] [Abstract][Full Text] [Related]
11. A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of rbp-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effects.
Nasser AF; Fudala PJ; Zheng B; Liu Y; Heidbreder C
J Addict Dis; 2014; 33(4):289-302. PubMed ID: 25299069
[TBL] [Abstract][Full Text] [Related]
12. Donepezil treatment and the subjective effects of intravenous cocaine in dependent individuals.
Grasing K; Mathur D; Newton TF; DeSouza C
Drug Alcohol Depend; 2010 Feb; 107(1):69-75. PubMed ID: 19836169
[TBL] [Abstract][Full Text] [Related]
13. Long-lasting decreases in cocaine-reinforced behavior following treatment with the cholinesterase inhibitor tacrine in rats selectively bred for drug self-administration.
Grasing K; He S; Yang Y
Pharmacol Biochem Behav; 2009 Nov; 94(1):169-78. PubMed ID: 19698738
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial].
Zhang Z; Wang X; Chen Q; Shu L; Wang J; Shan G
Zhonghua Yi Xue Za Zhi; 2002 Jul; 82(14):941-4. PubMed ID: 12181083
[TBL] [Abstract][Full Text] [Related]
15. Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans.
Smith BJ; Jones HE; Griffiths RR
Psychopharmacology (Berl); 2001 Aug; 156(4):435-44. PubMed ID: 11498721
[TBL] [Abstract][Full Text] [Related]
16. A phase II trial of huperzine A in mild to moderate Alzheimer disease.
Rafii MS; Walsh S; Little JT; Behan K; Reynolds B; Ward C; Jin S; Thomas R; Aisen PS;
Neurology; 2011 Apr; 76(16):1389-94. PubMed ID: 21502597
[TBL] [Abstract][Full Text] [Related]
17. Huperzine A for Alzheimer's disease.
Li J; Wu HM; Zhou RL; Liu GJ; Dong BR
Cochrane Database Syst Rev; 2008 Apr; (2):CD005592. PubMed ID: 18425924
[TBL] [Abstract][Full Text] [Related]
18. Huperzine-A response to cognitive impairment and task switching deficits in patients with Alzheimer's disease.
Gul A; Bakht J; Mehmood F
J Chin Med Assoc; 2019 Jan; 82(1):40-43. PubMed ID: 30839402
[TBL] [Abstract][Full Text] [Related]
19. Cocaine cardiovascular effects and pharmacokinetics after treatment with the acetylcholinesterase inhibitor donepezil.
Grasing K; Mathur D; DeSouza C; Newton TF; Moody DE; Sturgill M
Am J Addict; 2016 Aug; 25(5):392-9. PubMed ID: 27392137
[TBL] [Abstract][Full Text] [Related]
20. Effect of flupenthixol on subjective and cardiovascular responses to intravenous cocaine in humans.
Evans SM; Walsh SL; Levin FR; Foltin RW; Fischman MW; Bigelow GE
Drug Alcohol Depend; 2001 Nov; 64(3):271-83. PubMed ID: 11672942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
